AMPH
Amphastar Pharmaceuticals, Inc
$20.91
0.73 (3.62%) Today
— up— down
Market Cap
$892M-30.8%
Revenue (TTM)
$727.79M+1.0%
Net Income (TTM)
$75.38M-36.0%
EPS (TTM)
1.71-36.0%
Shares Out
44.09M
44.09MP/E Ratio
10.93
10.93Forward P/E
7.13
7.13Open
$20.91
$20.91Previous Close
$20.18
$20.18Day Range
$20.00 – $21.07
$20.00 – $21.0752-Week Range
$16.65 – $31.26
$16.65 – $31.26Beta
0.90
0.90Earnings Date
Nov 4, 2026
Nov 4, 2026Volume
299.88K
299.88KAvg Volume
569.03K
569.03KAnalyst Rating
Sell
SellExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout AMPH
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Related
News
N/AN/AN/AN/AN/A
UAE's ADNOC says one of its vessels came under attack while transiting Hormuz - Reuters
Reuters · 5h ago
Hormuz traffic slows further after US threatens more economic pressure on Iran - Reuters
Reuters · 6h ago
Trump says USS Abraham Lincoln deployment 'not nearly long enough' - Reuters
Reuters · 7h ago
Iran defiant on strait as Trump tells Americans to accept high gas prices - Reuters
Reuters · 8h ago
Mount Etna erupts in fiery display, disrupting hundreds of flights - Reuters
Reuters · 9h ago